A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19 q 13

Channing Laboratory and Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham & Women’s Hospital, Boston, MA, USA, Harvard School of Public Health, Boston, MA, USA, School of Public Health and School of Medicine, Boston University, Boston, MA, USA, Veterans Administration Boston Healthcare System, Boston, MA, USA, National Jewish Health, Denver, CO, USA, Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA, Johns Hopkins School of Public Health, Baltimore, MD, USA, GlaxoSmithKline Research and Development, Research Triangle Park, NC, USA, King of Prussia, PA, USA, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK, University of British Columbia Department of Radiology and James Hogg Research Centre, Institute for Heart and Lung Health, Vancouver, BC, Canada, University of Edinburgh, Edinburgh, UK, Hvidovre Hospital, Hvidovre, Denmark, Thorax Institute, Hospital Clinic IDIBAPS, Universitat Pompeu-Fabra (Barcelona) and CIBER Enfermedades Respiratorias (CIBERES), Fundación Caubet-Cimera, Mallorca, Spain, University Hospital Aintree, Liverpool, UK, University of Nebraska, Omaha, NE, USA, University of Maastricht, Maastricht, the Netherlands and Haukeland University Hospital and Institute of Medicine, University of Bergen, Bergen, Norway

[1]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[2]  Per Magne Ueland,et al.  Genetic Polymorphisms in 15q25 and 19q13 Loci, Cotinine Levels, and Risk of Lung Cancer in EPIC , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[3]  L. Bierut,et al.  The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European–Americans , 2011, Pharmacogenetics and genomics.

[4]  P. Sham,et al.  Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases , 2011, Genetic epidemiology.

[5]  J. Hokanson,et al.  Genome-wide association study of smoking behaviours in patients with COPD , 2012 .

[6]  N. Mehta Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.

[7]  Eleazar Eskin,et al.  Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. , 2011, American journal of human genetics.

[8]  D. Postma,et al.  Opportunities and Challenges in the Genetics of COPD 2010: An International COPD Genetics Conference Report , 2011, COPD.

[9]  G. Gamble,et al.  Individual and Cumulative Effects of GWAS Susceptibility Loci in Lung Cancer: Associations after Sub-Phenotyping for COPD , 2011, PloS one.

[10]  K. Morgan,et al.  The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication case-control study , 2011, BMC Medical Genetics.

[11]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[12]  G. Gamble,et al.  Chromosome 4q31 locus in COPD is also associated with lung cancer , 2010, European Respiratory Journal.

[13]  G. Abecasis,et al.  MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes , 2010, Genetic epidemiology.

[14]  Jiaquan Xu,et al.  Deaths: preliminary data for 2008. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[15]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[16]  William Wheeler,et al.  Multiple Independent Loci at Chromosome 15q25.1 Affect Smoking Quantity: a Meta-Analysis and Comparison with Lung Cancer and COPD , 2010, PLoS genetics.

[17]  Christopher I. Amos,et al.  Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5‐A3 genetic locus and lung cancer risk , 2010, Cancer.

[18]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[19]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[20]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[21]  C. Gieger,et al.  Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior , 2010, Nature Genetics.

[22]  Inês Barroso,et al.  Genome-wide association study identifies five loci associated with lung function , 2010, Nature Genetics.

[23]  Ming D. Li,et al.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.

[24]  A. Gulsvik,et al.  Case–control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? , 2010, The clinical respiratory journal.

[25]  Marc Decramer,et al.  The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. , 2010, American journal of respiratory and critical care medicine.

[26]  Christoph Lange,et al.  Variants in FAM13A are associated with chronic obstructive pulmonary disease , 2010, Nature Genetics.

[27]  Byron C. Wallace,et al.  The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. , 2009, Human molecular genetics.

[28]  A. Hofman,et al.  Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function , 2010, Nature Genetics.

[29]  A. Hofman,et al.  Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study , 2009, European Respiratory Journal.

[30]  K. Holland,et al.  Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development. , 2009, American journal of human genetics.

[31]  D. DeMeo,et al.  Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. , 2009, American journal of human genetics.

[32]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[33]  R. Tyndale,et al.  A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo , 2009, The Pharmacogenomics Journal.

[34]  D. Mannino,et al.  The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. , 2009, American journal of respiratory and critical care medicine.

[35]  H. O'brodovich,et al.  Global and gene-specific translational regulation in rat lung development. , 2009, American journal of respiratory cell and molecular biology.

[36]  K. Shianna,et al.  A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci , 2009, PLoS genetics.

[37]  Scott T. Weiss,et al.  A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study , 2009, PLoS genetics.

[38]  Andrew D. Johnson,et al.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..

[39]  Maarit Tiirikainen,et al.  Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. , 2008, Cancer research.

[40]  G. Gamble,et al.  Lung cancer gene associated with COPD: triple whammy or possible confounding effect? , 2008, European Respiratory Journal.

[41]  Manuel A. R. Ferreira,et al.  Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.

[42]  Yasutaka Nakano,et al.  Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[43]  R. Tyndale,et al.  Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent , 2008, Human mutation.

[44]  A. Bosserhoff,et al.  Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. , 2008, Developmental biology.

[45]  W. MacNee,et al.  Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.

[46]  J. Maurer Genetic Association Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease , 2008 .

[47]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[48]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[49]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[50]  Yurii S. Aulchenko,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm108 Genetics and population analysis GenABEL: an R library for genome-wide association analysis , 2022 .

[51]  M. Post,et al.  Hypoxia-inducible Factors in the First Trimester Human Lung , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[52]  C. Strange,et al.  Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency , 2007, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[53]  Edwin K Silverman,et al.  The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. , 2006, American journal of respiratory and critical care medicine.

[54]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[55]  J Vestbo,et al.  Developing COPD: a 25 year follow up study of the general population , 2006, Thorax.

[56]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[57]  Thomas A Trikalinos,et al.  Family-Based versus Unrelated Case-Control Designs for Genetic Associations , 2006, PLoS genetics.

[58]  E. Silverman,et al.  A functional mutation in the terminal exon of elastin in severe, early-onset chronic obstructive pulmonary disease. , 2005, American journal of respiratory cell and molecular biology.

[59]  N. Anthonisen,et al.  The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial , 2005 .

[60]  N. Laird,et al.  Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. , 2005, American journal of respiratory cell and molecular biology.

[61]  Neal L. Benowitz,et al.  Metabolism and Disposition Kinetics of Nicotine , 2005, Pharmacological Reviews.

[62]  Aravinda Chakravarti,et al.  Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies , 2004, Nature Genetics.

[63]  Christoph Lange,et al.  PBAT: tools for family-based association studies. , 2004, American journal of human genetics.

[64]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[65]  E. Silverman,et al.  Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. , 2003, Human molecular genetics.

[66]  J. Otte,et al.  Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. , 2002, Genes & development.

[67]  N. Wareham,et al.  Siblings of Patients with Severe Chronic Obstructive Pulmonary Disease Have a Significant Risk of Airflow Obstruction , 2002 .

[68]  E. Silverman,et al.  Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. , 2002, Human molecular genetics.

[69]  E. Silverman Genetic Epidemiology of COPD. , 2002, Chest.

[70]  张锺儒,et al.  对急性哮喘加剧的成年患者两种不同教育干预的评价[英]/Co^^té J…∥Am J Respir Crit Care Med , 2002 .

[71]  J. Twisk,et al.  Is calculating pack-years retrospectively a valid method to estimate life-time tobacco smoking? A comparison between prospectively calculated pack-years and retrospectively calculated pack-years. , 2001, Addiction.

[72]  R. Tyndale,et al.  Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. , 2000, Molecular pharmacology.

[73]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[74]  A. Buist,et al.  Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. , 1999, The American journal of medicine.

[75]  G. Coetzee,et al.  Genetic variation of CYP2A6, smoking, and risk of cancer , 1999, The Lancet.

[76]  B Rosner,et al.  Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[77]  N. Caporaso,et al.  Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. , 1997, Addictive behaviors.

[78]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[79]  Y. Funae,et al.  Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. , 1996, The Journal of pharmacology and experimental therapeutics.

[80]  E. Arnesen,et al.  Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. , 1996, Circulation.

[81]  W. Bailey,et al.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.

[82]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[83]  M. Lebowitz,et al.  Quantitative relationships between cigarette smoking and ventilatory function. , 1977, The American review of respiratory disease.

[84]  Albert Damon,et al.  The Normative Aging Study: An Interdisciplinary and Longitudinal Study of Health and Aging , 1972 .

[85]  R. K. Larson,et al.  The familial occurrence of chronic obstructive pulmonary disease. , 1965, Annals of internal medicine.